HLA-C and infection: They raise concerns regarding the possibility of infection, e.g., by SARS-CoV-2, due to immunologically cloaked transplants, and consider the applicability of hypoimmunogenic cells in therapies necessitating functional MHC presentation, including hematopoietic stem cell, immunological, and cutaneous disorders.